Immunoglobulin heavy chain V-D-J gene rearrangement and mutational status in Uruguayan patients with chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 51, Issue 11, 2010, Pages 2070-2078

  Bianchi, Sergio ^a,b   Moreno, Pilar ^a   Landoni, Ana Inés ^c   Naya, Hugo ^a   Oppezzo, Pablo ^a   Dighiero, Guillermo ^a   Gabs, Ral ^c   Pritsch, Otto ^a,d  

^a INSTITUT PASTEUR DE MONTEVIDEO   (Uruguay)

^b UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^c HOSPITAL MACIEL   (Uruguay)

^d DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

Author keywords

Chronic lymphocytic leukemia; gene usage; immunoglobulin variable heavy chain genes; mutational status

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN;

ADULT; AGED; ARTICLE; ASIAN; B CELL LEUKEMIA; BRAZIL; CHRONIC LYMPHATIC LEUKEMIA; COMPARATIVE STUDY; FEMALE; GENE LOCUS; GENE MUTATION; GENE REARRANGEMENT; GEOGRAPHIC ORIGIN; HUMAN; IMMUNOGLOBULIN HEAVY CHAIN GENE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POPULATION; PRIORITY JOURNAL;

ADULT; AGED; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; GENES, IMMUNOGLOBULIN HEAVY CHAIN; GEOGRAPHY; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; MUTATION; PHYLOGENY; URUGUAY;

EID: 78649243919     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2010.522283     Document Type: Article

References (50)

1. Dighiero G, Hamblin TJ. Chronic lymphocytic leukaemia. Lancet 2008;371:1017-1029.
2. Surveillance Epidemiology and End Results Cancer Statistics [Internet]. National Cancer Institute. [Accessed 4 June 2009.] Available from: http://seer.cancer.gov/statfacts/html/clyl.html
3. Shvidel L, Shtarlid M, Klepfish A, Sigler E, Berrebi A. Epidemiology and ethnic aspects of B cell chronic lymphocytic leukemia in Israel. Leukemia 1998;12:1612-1617.
4. Tamura K, Sawada H, Izumi Y, et al. Chronic lymphocytic leukemia (CLL) is rare, but the proportion of T-CLL is high in Japan. Eur J Haematol 2001;67:152-157.
5. Ruiz-Argüelles GJ, Velázquez BM, Apreza-Molina MG, Pérez-Romano B, Ruiz-Reyes G, Ruiz-Argüelles A. Chronic lymphocytic leukemia is infrequent in Mexican mestizos. Int J Hematol 1999;69:253-255.
6. Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999;94:1840-1847.
7. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V (H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999;94:1848-1854.
8. Maloum K, Davi F, Merle-Béral H, et al. Expression of unmutated VH genes is a detrimental prognostic factor in chronic lymphocytic leukemia. Blood 2000;96:377-379.
9. Schroeder HW Jr, Dighiero G. The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunol Today 1994;15:288-294.
10. Fais F, Ghiotto F, Hashimoto S, et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998;102:1515-1525.
11. Duke VM, Gandini D, Sherrington PD, et al. VH gene usage differs in germline and mutated B-cell chronic lymphocytic leukemia. Haematologica 2003;88:1259-1271.
12. Guarini A, Gaidano G, Mauro FR, et al. Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features. Blood 2003;102:1035-1041.
13. Stevenson FK, Caligaris-Cappio F. Chronic lymphocytic leukemia: revelations from the B-cell receptor. Blood 2004;103:4389-4395.
14. Chiorazzi N, Ferrarini M. B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annu Rev Immunol 2003;21:841-894.
15. Ghiotto F, Fais F, Valetto A, et al. Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J Clin Invest 2004;113:1008-1016.
16. Kolar GR, Capra JD. Ig V region restrictions in human chronic lymphocytic leukemia suggest some cases have a common origin. J Clin Invest 2004;113:952-954.
17. Ghia P, Stamatopoulos K, Belessi C, et al. Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. Blood 2005;105:1678-1685.
18. Tobin G, Thunberg U, Karlsson K, et al. Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood 2004;104:2879-2885.
19. Widhopf GF II, Rassenti LZ, Toy TL, Gribben JG, Wierda WG, Kipps TJ. Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood 2004;104:2499-2504.
20. Chen L, Zhang Y, Zheng W, et al. Distinctive IgVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemia. Leuk Res 2008;32:1491-1498.
21. Koiso H, Yamane A, Mitsui T, et al. Distinctive immunoglobulin VH gene usage in Japanese patients with chronic lymphocytic leukemia. Leuk Res 2006;30:272-276.
22. Hojjat Farsangi M, Jeddi-Tehrani M, Sharifian RA, et al. Analysis of the immunoglobulin heavy chain variable region gene expression in Iranian patients with chronic lymphocytic leukemia. Leuk Lymphoma 2007;48:109-116.
23. Hojjat-Farsangi M, Jeddi-Tehrani M, Razavi SM, et al. Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia. Cancer Sci 2009;100:2346-2353.
24. Mauerer K, Zahrieh D, Gorgun G, et al. Immunoglobulin gene segment usage, location and immunogenicity in mutated and unmutated chronic lymphocytic leukemia. Br J Haematol 2005;129:499-510.
25. Johnson TA, Rassenti LZ, Kipps TJ. Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. J Immunol 1997;158:235-246.
26. Widhopf GF II, Kipps TJ. Normal B cells express 51p1-encoded Ig heavy chains that are distinct from those expressed by chronic lymphocytic leukemia B cells. J Immunol 2001;166:95-102.
27. Potter KN, Orchard J, Critchley E, Mockridge CI, Jose A, Stevenson FK. Features of the overexpressed V1-69 genes in the unmutated subset of chronic lymphocytic leukemia are distinct from those in the healthy elderly repertoire. Blood 2003;101:3082-3084.
28. Pimentel BJ, Stefanoff CG, Santos Moreira A, Seuánez HN, Renault Zalcberg I. Use of VH, D and JH immunoglobulin gene segments in Brazilian patients with chronic lymphocytic leukaemia (CLL). Genet Mol Biol 2008;31:643-648.
29. Sans M. Admixture studies in Latin America: from the 20th to the 21st century. Hum Biol 2000;72:155-177.
30. Hidalgo PC, Bengochea M, Abilleira D, Cabrera A, Alvarez I. Genetic admixture estimate in the Uruguayan population based on the loci LDLR, GYPA, HBGG, GC and D7S8. Int J Hum Genet 2005;5:217-222.
31. Moro I, Foren L, Guillermo C, Borelli G, Pierri S, Gabús R. Primer registro nacional de leucemias. Paper presented at XI Uruguayan Hematology Congress, 19-21 November 2009. Punta del Este, Uruguay.
32. Hallek M, Cheson BD, Catovsky D, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008;111:5446-5456.
33. Binet JL, Lepoprier M, Dighiero G, et al. A clinical staging system for chronic lymphocytic leukemia: prognostic significance. Cancer 1977;40:855-864.
34. Comczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
35. Pritsch O, Magnac C, Dumas G, Egile C, Dighiero G. V gene usage by seven hybrids derived from CD5 + B cell chronic lymphocytic leukemia and displaying autoantibody activity. Blood 1993;82:3103-3112.
36. Maniatis T, Fritsch E, Sambrook J. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratories; 1982. p 545.
37. Brochet X, Lefranc MP, Giudicelli V. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res 2008;36:W503-W508.
38. Stamatopoulos K, Belessi C, Moreno C, et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood 2007;109:259-270.
39. Murray F, Darzentas N, Hadzidimitriou A, et al. Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood 2008;111:1524-1533.
40. Bomben R, Dal Bo M, Capello D, et al. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study. Br J Haematol 2009;144:492-506.
41. Chenna R, Sugawara H, Koike T, et al. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res 2003;31:3497-3500.
42. Matsuda F, Ishii K, Bourvagnet P, et al. The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus. J Exp Med 1998;188:2151-2162.
43. Tobin G, Soderberg O, Thunberg U, Rosenquist R. V (H) 3-21 gene usage in chronic lymphocytic leukemia-characterization of a new subgroup with distinct molecular features and poor survival. Leuk Lymphoma 2004;45:221-228.
44. H gene usage in a cohort of B-CLL patients from a northeastern region of Italy. Diagn Mol Pathol 2006;15:206-215.
45. Pritsch O, Troussard X, Magnac C, et al. VH gene usage by family members affected with chronic lymphocytic leukaemia. Br J Haematol 1999;107:616-624.
46. + B cells. J Clin Invest 1997;99:2488-2501.
47. Oppezzo P, Vuillier F, Vasconcelos Y, et al. Chronic lymphocytic leukemia B cells expressing AID display dissociation between class switch recombination and somatic hypermutation. Blood 2003;101:4029-4032.
48. Messmer BT, Albesiano E, Messmer D, Chiorazzi N. The pattern and distribution of immunoglobulin VH gene mutations in chronic lymphocytic leukemia B cells are consistent with the canonical somatic hypermutation process. Blood 2004;103:3490-3495.
49. Crespo M, Bosch F, Villamor N, et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003;348:1764-1775.
50. Irons RD, Le A, Bao L, et al. Characterization of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) in Shanghai, China: molecular and cytogenetic characteristics, IgV gene restriction and hypermutation patterns. Leuk Res 2009;33:1599-1603.